72.40
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Bio Techne Corp Aktie (TECH) Neueste Nachrichten
Insider Activity Update: John L Higgins Executes Options Exercise, Resulting In $751K At Bio-Techne - Benzinga
Form 4 Bio-Techne Corp For: 1 October By Investing.com - Investing.com Canada
At $25.30 each, Bio-Techne (TECH) director John L. Higgins exercises 15,940 options. - Stock Titan
INCY or TECH: Which Is the Better Value Stock Right Now? - Zacks Investment Research
Bio-Techne Corporation (TECH) Stock Price, News, Quote & History - Yahoo! Finance Canada
Precision Trading with Bio-techne Corp (TECH) Risk Zones - Stock Traders Daily
Bio-Techne (TECH) Shareholders Approve the Merck KGaA Takeover and Reject the Pay Package - Yahoo Finance
Robert V Baumgartner Exercises Options, Realizes $754K - Benzinga
What Does Bio-Techne Corporation's (TECH) Latest Move Mean for Midcap Stocks Investors? - Kalkine Media
Form 4 Bio-Techne Corp For: 25 September By Investing.com - Investing.com Canada
Bio-Techne (TECH) director exercises options and delivers or withholds 5,559 shares for costs or taxes. - Stock Titan
Bio-Techne shareholders approve $11.3 billion merger with German Merck - AKM.RU
What Does Shareholder Approval Mean for Bio-Techne's (NASDAQ:TECH) Merck KGaA Deal? - Kalkine Media
Is Bio-Techne Stock Outperforming the Nasdaq? - Yahoo Finance
Form 8K Bio-Techne Corp For: 23 September By Investing.com - Investing.com Canada
Merck KGaA's USD 11.3b Bio-Techne acquisition clears final shareholder approval hurdle - AllSci
Bio-Techne (TECH) Opens Düsseldorf Hub As Fair Value Questions Come Into Focus - simplywall.st
Bio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, Germany - Investing News Network
Bio-Techne shareholders approve Merck KGaA acquisition - Investing.com
Bio-Techne Shareholders Approve Takeover by Merck KGaA - marketscreener.com
Bio-Techne Opens New Customer Experience Center in Düsseldorf to Accelerate Scientific Discovery and Customer Collaboration - Investing News Network
Bio-Techne Opens New Customer Experience Center in Germany - marketscreener.com
Bio-Techne opens customer experience center in Düsseldorf - Investing.com
Bio-Techne opens customer experience center in Düsseldorf By Investing.com - Investing.com Canada
Bio-Techne Corp (TECH) Investor Outlook: Navigating Market Dynamics with a Focus on Growth Potential - DirectorsTalk Interviews
Ademi LLP investigates Bio-Techne sale to Merck KGaA - scanx.trade
Bio-Techne Corporation (TECH) Options ChainYahoo Finance - Yahoo! Finance Canada
Bio-Techne issues supplemental merger disclosures amid shareholder lawsuit - Investing.com
Form 8K Bio-Techne Corp For: 14 September By Investing.com - Investing.com Nigeria
Bio-Techne supplements proxy disclosures after shareholder suit, seeks shareholder vote on Sept. 23 - TradingView
Why Is Techne (TECH) Down 0.1% Since Last Earnings Report? - Eastern Progress
TECH: Bio-Techne Corp Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Research Use Recombinant Protein Market Report Now Available — Forecasts Market Growth from $1.11B (2026) to $1.55B by 2031, Profiling Thermo Fisher, Bio-Techne, Merck KGaA, Danaher, Revvity, and Others - Yahoo Finance UK
IVD Raw Material Market Report Now Available — Forecasts Market Growth from $21.5B (2026) to $31.1B by 2031, Profiling Merck KGaA, Thermo Fisher, Bio-Techne, Fapon Biotech, and 21 Other Key Players - Yahoo Finance
Bio-Techne Corp (TECH) Stock Analysis: Navigating Its Current Valuation and Growth Potential - DirectorsTalk Interviews
Bio-Techne Corp (NASDAQ: TECH) Share Price, TECH Stock News, TECH Share Price & Updates - Kalkine
Global Multiplex Assays Market 2026 Edition - GlobeNewswire Inc.
Bio-Techne Corp (TECH) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Bio-Techne (TECH), What Is Behind The Latest Attention? - simplywall.st
Bio-Techne Achieves Science Based Targets Validation and Reports Significant Progress Toward Climate Goals - Investing News Network
Legal & General buys $19.51M stake in Bio-Techne - Dealroom
Bio-Techne Corp (TECH) Stock Analysis: Evaluating the Balance Between Growth Potential and Current Valuation - DirectorsTalk Interviews
Bio-Techne Corp (TECH) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Bio-Techne To Be Acquired by Merck KGaA - Morningstar
Bio-Techne draws fresh institutional cash as revenue climbs to $321M - app.dealroom.co
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):